VOR Logo

Vor Biopharma Inc. (VOR) 

NASDAQ
Market Cap
$78.5M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
452 of 809
Rank in Industry
247 of 445

Largest Insider Buys in Sector

VOR Stock Price History Chart

VOR Stock Performance

About Vor Biopharma Inc.

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Insider Activity of Vor Biopharma Inc.

Over the last 12 months, insiders at Vor Biopharma Inc. have bought $0 and sold $20,357 worth of Vor Biopharma Inc. stock.

On average, over the past 5 years, insiders at Vor Biopharma Inc. have bought $73.63M and sold $5.07M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,979,566 shares for transaction amount of $53.63M was made by RA CAPITAL MANAGEMENT, L.P. () on 2021‑02‑09.

List of Insider Buy and Sell Transactions, Vor Biopharma Inc.

2024-06-03SaleAttar Eyal C.CHIEF MEDICAL OFFICER
14,645
0.0209%
$1.39$20,357-13.29%
2021-11-16SalePARMAR KUSH
330,706
0.7914%
$15.30$5.06M-69.06%
2021-11-16Sale5AM Ventures VI, L.P.10 percent owner
330,706
0.7914%
$15.30$5.06M-69.06%
2021-02-09PurchaseRA CAPITAL MANAGEMENT, L.P.
2.98M
5.6047%
$18.00$53.63M-63.24%
2021-02-09PurchasePARMAR KUSH
555,555
1.045%
$18.00$10M-63.24%
2021-02-09Purchase5AM Ventures VI, L.P.10 percent owner
555,555
1.045%
$18.00$10M-63.24%

Insider Historical Profitability

<0.0001%
Attar Eyal C.CHIEF MEDICAL OFFICER
96063
0.1407%
$1.1501
RA CAPITAL MANAGEMENT, L.P.
8297265
12.2368%
$1.1510<0.0001%
PARMAR KUSH
1766634
2.6054%
$1.1511<0.0001%
5AM Ventures VI, L.P.10 percent owner
1766634
2.6054%
$1.1511<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
RA Capital Management, L.P.$53.91M33.3322.75M0%+$00.05
Fidelity Investments$18.03M11.157.61M-0.14%-$24,906.33<0.01
Paradigm BioCapital Advisors LP$15.3M9.466.46M0%+$00.56
5Am Venture Management Llc$15.08M9.326.36M0%+$01.02
Laurion Capital Management LP$7.54M4.663.18M0%+$00.21
BlackRock$5.33M3.292.25M-0.18%-$9,368.61<0.0001
The Vanguard Group$4.3M2.661.81M+3.98%+$164,563.30<0.0001
Woodline Partners LP$2.63M1.631.11M0%+$00.03
Johnson & Johnson$2.55M1.571.07M0%+$00.06
Artal Group S A$2.37M1.471M-57.4%-$3.19M0.01
Geode Capital Management$1.99M1.23841,208+5.94%+$111,746.60<0.0001
State Street$1.56M0.96657,707+8.17%+$117,789.03<0.0001
Sarissa Capital Management LP$1.46M0.91618,0000%+$00.26
Northern Trust$944,118.000.58398,362+0.29%+$2,704.17<0.0001
MAI Capital Management, LLC$867,086.000.54365,859+2.44%+$20,637.960.01
Ensign Peak Advisors Inc$820,226.000.51346,0870%+$0<0.01
Renaissance Technologies$793,000.000.49334,658+548.56%+$670,729.50<0.01
Millennium Management LLC$375,389.000.23158,392New+$375,389.00<0.0001
Exchange Traded Concepts, LLC$366,013.000.23154,436+156.67%+$223,410.230.01
Bridgeway Capital Management$314,499.000.19132,700-18.44%-$71,100.000.01
Morgan Stanley$300,261.000.19126,692-26.37%-$107,524.87<0.0001
BNY Mellon$247,787.000.15104,551-3.38%-$8,669.50<0.0001
Charles Schwab$246,286.000.15103,9180%+$0<0.0001
Goldman Sachs$220,815.000.1493,171+143.04%+$129,958.79<0.0001
Marshall Wace$180,864.000.1176,314New+$180,864.00<0.0001
Nuveen$169,464.000.1171,5040%+$0<0.0001
The Bollard Group$132,000.000.0855,5550%+$0<0.01
Acadian Asset Management$126,000.000.0853,708New+$126,000.00<0.0001
Citadel Advisors LLC$106,835.000.0745,078+47.09%+$34,203.89<0.0001
RhumbLine Advisers$103,489.000.0643,670+1.58%+$1,611.46<0.0001
LMR PARTNERS LLP$96,926.000.0640,897-19.98%-$24,207.21<0.01
UBS$90,968.000.0638,383+1.19%+$1,066.50<0.0001
Barclays$91,000.000.0638,475-26.12%-$32,178.17<0.0001
Deutsche Bank$75,449.000.0531,8350%+$0<0.0001
Bourgeon Capital Management, LLC.$69,797.000.0429,4500%+$00.01
Bank of America$67,882.000.0428,642-46.51%-$59,011.03<0.0001
Susquehanna International Group$62,997.000.0426,581-58.19%-$87,685.30<0.0001
Dimensional Fund Advisors$59,058.000.0424,919+21.64%+$10,506.20<0.0001
Bank of Montreal$53,297.000.0322,488New+$53,297.00<0.0001
New York State Common Retirement Fund$52,000.000.0321,867+1.73%+$884.62<0.0001
Jane Street Capital$46,196.000.0319,492+15.03%+$6,036.39<0.0001
Money Concepts$47,400.000.0320,000New+$47,400.000.01
American International Group$44,577.000.0318,809+0.44%+$194.34<0.0001
Xtx Topco Ltd$44,189.000.0318,645New+$44,189.00<0.01
Chicago Partners Wealth Advisors$33,942.000.0318,054+4.24%+$1,379.94<0.01
HSBC$41,961.000.0317,705New+$41,961.00<0.0001
Invesco$41,196.000.0317,382-3.64%-$1,554.74<0.0001
JPMorgan Chase$38,363.000.0216,187-33.92%-$19,696.97<0.0001
Walleye Capital$39,224.000.0216,550New+$39,224.00<0.0001
Voya Investment Management LLC$34,761.000.0214,667-7.72%-$2,908.01<0.0001